ID
13637
Description
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00006232
Link
https://clinicaltrials.gov/show/NCT00006232
Keywords
Versions (1)
- 2/22/16 2/22/16 -
Uploaded on
February 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00006232
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00006232
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00006232
- StudyEvent: Eligibility
C1300072 (UMLS CUI [2])
C0201976 (UMLS CUI [2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0006147 (UMLS CUI [1,2])